in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
API business of Dr. Reddy’s reports rise in sales
8:16 AM MDT | July 31, 2013 | Deepti Ramesh
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 6.1% rise in sales in the company’s fiscal first quarter, ended 30 June, compared with the year-ago quarter, to 5.86 billion Indian rupees ($96 million). Earnings figures for the PSAI business have not been disclosed. Growth in the business was muted because of fewer launch molecules to customers during the quarter, Dr. Reddy’s says. During the quarter, five drug master files (DMF) were filed globally...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee